Title:
SYNOVIUM-TARGETING COMPOUND AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/043523
Kind Code:
A1
Abstract:
The present invention relates to a compound specifically targeting synovium, and uses thereof. The compound prepared according to the present invention exhibits no toxicity in vitro and in vivo, is stable in biological environments, can specifically target and visualize synovial cells and synovial areas in the body, and thus can be used in drug development and medical fields and be effectively used in the diagnosis and treatment of synovium-associated diseases.
Inventors:
KIM DOKYOUNG (KR)
KIM JAEHOON (KR)
KIM JAEHOON (KR)
Application Number:
PCT/KR2023/009907
Publication Date:
February 29, 2024
Filing Date:
July 12, 2023
Export Citation:
Assignee:
UNIV INDUSTRY COOPERATION GROUP KYUNG HEE UNIV (KR)
International Classes:
C07K5/093; A61K47/64; A61K49/00; A61P19/02
Domestic Patent References:
| WO2021113434A1 | 2021-06-10 |
Foreign References:
| KR20210077261A | 2021-06-25 | |||
| US20050100555A1 | 2005-05-12 | |||
| KR20220116459A | 2022-08-23 | |||
| US20070265212A1 | 2007-11-15 |
Other References:
KIM JAEHOON; AN JONG MIN; KIM YOUNGWOONG; JIN JI HYE; KIM SUNG SOO; KANG RAE HYUNG; KIM DOKYOUNG: "TAMRA-conjugated DRL tripeptide for the visualization of synovium", DYES AND PIGMENTS, ELSEVIER APPLIED SCIENCE PUBLISHERS BARKING, GB, vol. 205, 19 July 2022 (2022-07-19), GB , XP087136775, ISSN: 0143-7208, DOI: 10.1016/j.dyepig.2022.110590
Attorney, Agent or Firm:
WIE, Byoung Gap (KR)
Download PDF: